subject area of
- Bicyclic thiazolidine lactam peptidomimetics of the dopamine receptor modulating peptide Pro-Leu-Gly-NH2 Journal Articles
-
Design, Synthesis, and Dopamine Receptor Modulating Activity of Spiro Bicyclic Peptidomimetics of
l -Prolyl-l -leucyl-glycinamide Journal Articles - Development of Methods for the Synthesis of Libraries of Substituted Maleimides and α,β-Unsaturated-γ-butyrolactams Journal Articles
- Diversity-Oriented Synthesis and Preliminary Biological Screening of Highly Substituted Five-Membered Lactones and Lactams Originating From an Allyboration of Aldehydes and Imines Journal Articles
- Dopamine receptor modulation by conformationally constrained analogs of Pro-Leu-Gly-NH2 Journal Articles
- Editorial Commentary: What is Optimal Antimicrobial Therapy for Bacteremic Pneumococcal Pneumonia? Journal Articles
- Guidelines for Empiric Antimicrobial Prescribing in Community-Acquired Pneumonia Journal Articles
- In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir–ritonavir improved outcomes Journal Articles
- Pramanicin, an antifungal agent, raises cytosolic Ca2+ and causes cell death in vascular endothelial cells Journal Articles
-
Synthesis and Dopamine Receptor Modulating Activity of 3-Substituted γ-Lactam Peptidomimetics of
l -Prolyl-l -leucyl-glycinamide Journal Articles -
Synthesis and Dopamine Receptor Modulating Activity of Substituted Bicyclic Thiazolidine Lactam Peptidomimetics of
l -Prolyl-l -leucyl-glycinamide Journal Articles - Synthesis and dopamine receptor modulating activity of lactam conformationally constrained analogs of Pro-Leu-Gly-NH2 Journal Articles
- The Epoxy Group of Pramanicin Is Required for the Optimal Endothelium-Dependent Relaxation of Rat Aorta Journal Articles
- Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline Journal Articles
- Vasorelaxant Effects of Pramanicin, an Anti-fungal Agent: Selective Action on Endothelial Cells Journal Articles
- iso-Lactam and reduced amide analogues of the peptidomimetic dopamine receptor modulator 3(R)-[(2(S)-Pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide Journal Articles